The anthem of academic medicine.

1/ The long-awaited OS results from #KEYNOTE -564 are out NEJM! The 1st phase 3 trial to demonstrate a survival benefit for adjuvant treatment in #RCC .

nejm.org/doi/full/10.10…

A huge milestone in #kidneycancer therapy! Hats off to Toni Choueiri, MD Tom Powles & team for leading this pivotal study - & many thanks to the thousands of patients who have participated in adjuvant trials (this & so many others) over the past several decades. Without their courage…

Fantastic presentation by Shuchi Gulati MD on “Metabolic Adaptations in Kidney Cancer”. The James Ohio State Wexner Medical Center Urology Dept. Ohio State Medical Oncology UC Davis Health

Just in Kidney Cancer 👉Insightful commentary by Shuchi Gulati MD @primolaraMD on recent LITESPARK-005 data from #ESMO23  in advanced ccRCC #kidneycancer 👉belzutifan showed improved PFS & QoL outcomes over everolimus👇👇 tinyurl.com/37zyyee9 OncoAlert UroToday.com KidneyCAN

Terrific news Tian Zhang, MD, MHS!

A heartwarming finish to my clinic day — taking on the AD of clinical research role is a huge opportunity to contribute to our UTSW Simmons Cancer Center center. Have been working from division level over past yr & hope to continue our efforts forward in expanding our trial portfolios!

Thrilled – Thanks God – to finally bring this to the finish line. “Cancer in Halachah” covers the medical and halachic (Jewish law/ethics) considerations of cancer screening and treatment. Full of practical advice and suggestions for patients.

israelbookshoppublications.com/store/pc/Cance…

Although women are much more broadly represented in the cancer research workplace today, there are still both overt + subtle challenges to a woman chasing her dream. We need to recognize and address these barriers when we find them. #WomenInScience #WomenInSTEM #WomenInMedicine

Happy International Day of Women and Girls in Science! We are beyond proud of our fellow #WomenInScience , especially those dedicated to helping find a cure for #kidneycancer . 🧡💪

Tomorrow is #NationalWomenPhysiciansDay . Thank you to our women physicians at National Cancer Institute and across the country for your critical roles in patient care, medical research, and leadership within the cancer community. Your efforts make a difference. 💪 👩‍🔬

Registration for SWOG's spring group meeting is open! Mtg will be in Seattle, April 3-6. Register and reserve your hotel room and travel early (travel for the Apr 8 eclipse may make it harder to get a flight). #SWOGonc
swog.org/news-events/sw…

ASCO friends! We need your help — join me & my LDP team for a one hour zoom focus group & help improve ASCO member engagement.
Feb 1, 5, 15, 19 or 26th 5pm EST

Sign up here!
surveymonkey.com/r/asco2024_ldp…

Hematology & Oncology Women Physicians Group—HOWPG OncoAlert Kidney Cancer UTSW Simmons Cancer Center

Thanks @Onclive for highlighting our National Comprehensive Cancer Network (NCCN) YIA supported biomarker study for RCC now open at O'Neal Comprehensive Cancer Center at UAB. Key to improving risk/benefit in RCC

Arpita Desai Benjamin L Maughan Pedro C Barata, MD MSc FACP Shuchi Gulati MD Rohan Garje, MD Brian Rini, MD Hans Hammers

onclive.com/view/dr-basu-o… via @onclive

There comes a time in a PIs life where they rip free of the chains that bind them, and simply say all the things they want to say about a great paper. So here we go, a new paper driven by Mahnoor M and led by Payam A. Gammage and I: nature.com/articles/s4301… Prepare to be annoyed

⭐️Best part of ASCO GU are our friends and colleagues. #Highlights #GU24

Yüksel Ürün Shilpa Gupta Toni Choueiri, MD Sumanta K. Pal, MD, FASCO Andrea Necchi Neeraj Agarwal, MD, FASCO Amanda Nizam, MD Albert Jang, MD Dr. Bishoy M. Faltas Tian Zhang, MD, MHS Cristiane D Bergerot Laura Bukavina David Braun Emre Yekedüz

Walking the walk! Started the weekend off right by getting my screening #mammogram . You can use the MyHealthfinder Tool to learn what cancer screenings and other preventive services are recommended for you. #CancerScreening
health.gov/myhealthfinder

Safety of pegfilgastrim in patients with germ cell tumors treated with bleomycin-containing regimens. No increased risk of lung toxicity! IU Simon Comprehensive Cancer Center Jennifer King IU School of Medicine Department of Medicine Rebecca Hassoun

My late husband was a fainter. He hated it when I said that! But it was a necessary warning everytime he needed an IV. Sincere gratitude to Saby George and Bristol Myers Squibb for #checkmate67T . Trials aimed at reducing treatment burden can make a meaningful difference for #kidneycancer …

#GU24 : Remarkable long term follow up for front-line advanced #RCC treatment -- on same day as generational OS data for adjuvant therapy from KN-564
🚨 👏
Toni Choueiri, MD Tom Powles Brian Rini, MD Robert Motzer MD Sumanta K. Pal, MD, FASCO Daniel Heng Laurence Albiges Rana McKay Camillo Porta OncoAlert The View on GU | with Lalani & Wallis